世界の全エクソームシーケンス市場2023-2030:製品別(機器、消耗品、サービス)、技術別、ワークフロー別、用途別、エンドユーザー別、地域別

【英語タイトル】Whole Exome Sequencing Market Size, Share & Trends Analysis Report By Product (Instruments, Consumables, Services), By Technology, By Workflow, By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030

Grand View Researchが出版した調査資料(GRV23JUN109)・商品コード:GRV23JUN109
・発行会社(調査会社):Grand View Research
・発行日:2023年5月19日
・ページ数:180
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:バイオ
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥904,400見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥1,056,400見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥1,360,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

Grand View Research社の市場調査書によると、世界の全エクソームシーケンス市場規模が、予測期間中に年平均17.48%増加し、2030年までに12.7億ドルへ達すると見込まれています。本調査書では、全エクソームシーケンスの世界市場を調査対象とし、調査手法・範囲、エグゼクティブサマリー、市場変動・動向・範囲、製品別(機器、消耗品、サービス)分析、技術別(合成、イオン半導体、その他)分析、ワークフロー別(プレシーケンス、シーケンス、データ分析)分析、用途別(臨床診断、創薬・医薬品開発、個別化医薬品、その他)分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)分析、競争状況などについて調査・分析し、まとめています。なお、こちらに掲載されている企業情報には、Thermo Fisher Scientific, Inc.、Illumina, Inc.、Agilent Technologies, Inc、BGI、PacBio、Oxford Nanopore Technologies plc.、Azenta US Inc. (GENEWIZ)、CD Genomics、Novogene Co, Ltd、Eurofins Genomicsなどが含まれています。
・調査手法・範囲
・エグゼクティブサマリー
・市場変動・動向・範囲
・世界全エクソームシーケンスの市場規模:製品別
- 機器の市場規模
- 消耗品の市場規模
- サービスの市場規模
・世界全エクソームシーケンスの市場規模:技術別
- 合成における市場規模
- イオン半導体における市場規模
- その他技術における市場規模
・世界全エクソームシーケンスの市場規模:ワークフロー別
- プレシーケンスにおける市場規模
- シーケンスにおける市場規模
- データ分析における市場規模
・世界全エクソームシーケンスの市場規模:用途別
- 臨床診断における市場規模
- 創薬・医薬品開発における市場規模
- 個別化医薬品における市場規模
- その他用途における市場規模
・世界全エクソームシーケンスの市場規模:地域別
- 北米の全エクソームシーケンス市場規模
- ヨーロッパの全エクソームシーケンス市場規模
- アジア太平洋の全エクソームシーケンス市場規模
- 中南米の全エクソームシーケンス市場規模
- 中東・アフリカの全エクソームシーケンス市場規模
・競争状況

全エクソームシーケンス市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界の全エクソームシーケンス市場規模は2030年までに12億7000万米ドルに達し、予測期間中のCAGRは17.48%を記録すると予測されています。市場を牽引する主な要因の1つは、全エクソームシーケンス技術の進歩です。ハイスループット技術は、医師がエクソーム配列障害をよりよく理解し、それに応じて治療を行うのに役立つ臨床診断や研究において、より広く使用されるようになってきています。さらに、遺伝的疾患の有病率の上昇により、タンパク質コード領域の調査や遺伝的変異に関する貴重なアウトプットの導出のための全エクソームシーケンスの採用が可能になりました。

さらに、全エクソームを含む研究が大幅に増加しているのは、データ解析および解釈ソフトウェアが利用可能になっているためです。遺伝子データを調べるためにこれらのツールやソフトウェアを使用することは容易であり、遺伝子異常や疾患の根本的な原因に関する新鮮な洞察を提供します。例えば、2022年5月、 Illumina社の子会社であるGrail社は、米国退役軍人省との提携を発表し、同社のギャレリ・マルチがん早期発見検査を米国の退役軍人に提供しました。この検査は全エクソーム配列を利用し、複数の種類のがんを初期段階で検出します。このパートナーシップは、全エクソームシーケンスと高度なデータ解析ツールの利用がいかに大規模なゲノム研究を可能にし、精密医療の未来を変えるかを例証するものです。

市場はCOVID-19の大流行により大きな影響を受けています。ウイルスとその伝播の理解を深めるために全エクソームが使用された例として、COVID-19ゲノミクスUKコンソーシアム研究があります。パンデミックはまた、感染症との闘いにおけるエクソーム配列の有望性に注目を集め、この研究分野への追加投資に拍車をかけました。2020年のパンデミックによってもたらされた困難にもかかわらず、市場全体は今後数年で発展すると予測されています。

全エクソームシーケンス市場レポートハイライト

– 製品別では、キット、試薬、その他の研究用消耗品のような消耗品を大量に必要とする遺伝子検査や研究の需要が高いことから、消耗品セグメントが2022年の市場を支配し、62.91%のシェアを占めると予測されます。

– 技術別では、合成によるシーケンシングセグメントが2022年に73.50%のシェアで市場を席巻しました。

– ワークフロー別では、シーケンスセグメントが49.94%のシェアで2022年の市場の首位に立ちました。このため、研究および臨床アプリケーションにおけるシーケンスワークフローの需要が高まっています。

– 用途別では、創薬および薬剤開発が市場で圧倒的な存在感を示し、2022年のシェアは48.18%でした。これは、疾患の遺伝的基盤や薬剤反応に関する貴重なアウトプットを提供する能力があり、個別化された標的療法の開発に役立つためです。

– 最終用途別では、学術・研究機関分野が2022年に47.32%の最大市場シェアを占めました。これは、ゲノム研究分野への投資が高く、学術・研究分野でこの技術に対する需要が高まっているためです。

– 北米は、高度に発達した医療インフラと有利な政府政策により、2022年には50.52%のシェアを獲得し、同市場において確固たる地位を確立しました。

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

Table of Contents

Chapter 1. Methodology and Scope
1.1. Information Procurement
1.2. Information Or Data Analysis
1.3. Market Scope & Segment Definition
1.4. Market Model
1.4.1. Market Study, By Company Market Share
1.4.2. Regional Analysis
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Growing Prevalence of Genetic Diseases
3.2.1.2. Technological Advancements in Sequencing Platforms and Data Analysis Tools
3.2.1.3. Decreasing Costs of Sequencing
3.2.2. Market Restraint Analysis
3.2.2.1. High Complexity and Costs Associated with Data Storage, Interpretation & Analysis
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Product Business Analysis
4.1. Whole Exome Sequencing Market: Product Movement Analysis
4.2. Instruments
4.2.1. Instruments Market, 2018 – 2030 (USD Million)
4.3. Consumables
4.3.1. Consumables Market, 2018 – 2030 (USD Million)
4.4. Services
4.4.1. Services Market, 2018 – 2030 (USD Million)
Chapter 5. Technology Business Analysis
5.1. Whole Exome Sequencing Market: Technology Movement Analysis
5.2. Sequencing by Synthesis
5.2.1. Sequencing By Synthesis Market, 2018 – 2030 (USD Million)
5.3. ION Semiconductor Sequencing
5.3.1. ION Semiconductor Sequencing Market, 2018 – 2030 (USD Million)
5.4. Others
5.4.1. Other Technology Market, 2018 – 2030 (USD Million)
Chapter 6. Workflow Business Analysis
6.1. Whole Exome Sequencing Market: Workflow Movement Analysis
6.2. Pre-Sequencing
6.2.1. Pre-Sequencing Market, 2018 – 2030 (USD Million)
6.3. Sequencing
6.3.1. Sequencing Market, 2018 – 2030 (USD Million)
6.4. Data Analysis
6.4.1. Data Analysis Workflow Market, 2018 – 2030 (USD Million)
Chapter 7. Application Business Analysis
7.1. Clinical Diagnostics
7.1.1. Clinical Diagnostics Market, 2018 – 2030 (USD Million)
7.2. Drug Discovery & Development
7.2.1. Drug Discovery & Development Market, 2018 – 2030 (USD Million)
7.3. Personalized Medicines
7.3.1. Personalized Medicines Market, 2018 – 2030 (USD Million)
7.4. Others
7.4.1. Other Application Market, 2018 – 2030 (USD Million)
Chapter 8. End-Use Business Analysis
8.1. Academic And Research Institutes
8.1.1. Academic And Research Institutes Market, 2018 – 2030 (USD Million)
8.2. Hospitals & Clinics
8.2.1. Hospitals & Clinics Market, 2018 – 2030 (USD Million)
8.3. Pharmaceutical & Biotechnology Companies
8.3.1. Pharmaceutical & Biotechnology Companies Market, 2018 – 2030 (USD Million)
8.4. Others
8.4.1. Other End-use Market, 2018 – 2030 (USD Million)
Chapter 9. Regional Business Analysis
9.1. Whole Exome Sequencing Market Share By Region, 2022 & 2030
9.2. North America
9.2.1. SWOT Analysis
9.2.2. North America Whole Exome Sequencing Market, 2018 – 2030 (USD Million)
9.2.3. U.S.
9.2.3.1. Key Country Dynamics
9.2.3.2. Target Disease Prevalence
9.2.3.3. Competitive Scenario
9.2.3.4. Regulatory Framework
9.2.3.5. U.S. Whole Exome Sequencing Market, 2018 – 2030 (USD Million)
9.2.4. Canada
9.2.4.1. Key Country Dynamics
9.2.4.2. Target Disease Prevalence
9.2.4.3. Competitive Scenario
9.2.4.4. Regulatory Framework
9.2.4.5. Canada Whole Exome Sequencing Market, 2018 – 2030 (USD Million)
9.3. Europe
9.3.1. SWOT Analysis
9.3.2. Europe Whole Exome Sequencing Market, 2018 – 2030 (USD Million)
9.3.3. UK
9.3.3.1. Key Country Dynamics
9.3.3.2. Target Disease Prevalence
9.3.3.3. Competitive Scenario
9.3.3.4. Regulatory Framework
9.3.3.5. UK Whole Exome Sequencing Market, 2018 – 2030 (USD Million)
9.3.4. Germany
9.3.4.1. Key Country Dynamics
9.3.4.2. Target Disease Prevalence
9.3.4.3. Competitive Scenario
9.3.4.4. Regulatory Framework
9.3.4.5. Germany Whole Exome Sequencing Market, 2018 – 2030 (USD Million)
9.3.5. France
9.3.5.1. Key Country Dynamics
9.3.5.2. Target Disease Prevalence
9.3.5.3. Competitive Scenario
9.3.5.4. Regulatory Framework
9.3.5.5. France Whole Exome Sequencing Market, 2018 – 2030 (USD Million)
9.3.6. Italy
9.3.6.1. Key Country Dynamics
9.3.6.2. Target Disease Prevalence
9.3.6.3. Competitive Scenario
9.3.6.4. Regulatory Framework
9.3.6.5. Italy Whole Exome Sequencing Market, 2018 – 2030 (USD Million)
9.3.7. Spain
9.3.7.1. Key Country Dynamics
9.3.7.2. Target Disease Prevalence
9.3.7.3. Competitive Scenario
9.3.7.4. Regulatory Framework
9.3.7.5. Spain Whole Exome Sequencing Market, 2018 – 2030 (USD Million)
9.3.8. Denmark
9.3.8.1. Key Country Dynamics
9.3.8.2. Target Disease Prevalence
9.3.8.3. Competitive Scenario
9.3.8.4. Regulatory Framework
9.3.8.5. Denmark Whole Exome Sequencing Market, 2018 – 2030 (USD Million)
9.3.9. Sweden
9.3.9.1. Key Country Dynamics
9.3.9.2. Target Disease Prevalence
9.3.9.3. Competitive Scenario
9.3.9.4. Regulatory Framework
9.3.9.5. Sweden Whole Exome Sequencing Market, 2018 – 2030 (USD Million)
9.3.10. Norway
9.3.10.1. Key Country Dynamics
9.3.10.2. Target Disease Prevalence
9.3.10.3. Competitive Scenario
9.3.10.4. Regulatory Framework
9.3.10.5. Norway Whole Exome Sequencing Market, 2018 – 2030 (USD Million)
9.4. Asia Pacific
9.4.1. SWOT Analysis
9.4.2. Asia Pacific Whole Exome Sequencing Market, 2018 – 2030 (USD Million)
9.4.3. Japan
9.4.3.1. Key Country Dynamics
9.4.3.2. Target Disease Prevalence
9.4.3.3. Competitive Scenario
9.4.3.4. Regulatory Framework
9.4.3.5. Japan Whole Exome Sequencing Market, 2018 – 2030 (USD Million)
9.4.4. China
9.4.4.1. Key Country Dynamics
9.4.4.2. Target Disease Prevalence
9.4.4.3. Competitive Scenario
9.4.4.4. Regulatory Framework
9.4.4.5. China Whole Exome Sequencing Market, 2018 – 2030 (USD Million)
9.4.5. India
9.4.5.1. Key Country Dynamics
9.4.5.2. Target Disease Prevalence
9.4.5.3. Competitive Scenario
9.4.5.4. Regulatory Framework
9.4.5.5. India Whole Exome Sequencing Market, 2018 – 2030 (USD Million)
9.4.6. Australia
9.4.6.1. Key Country Dynamics
9.4.6.2. Target Disease Prevalence
9.4.6.3. Competitive Scenario
9.4.6.4. Regulatory Framework
9.4.6.5. Australia Whole Exome Sequencing Market, 2018 – 2030 (USD Million)
9.4.7. Thailand
9.4.7.1. Key Country Dynamics
9.4.7.2. Target Disease Prevalence
9.4.7.3. Competitive Scenario
9.4.7.4. Regulatory Framework
9.4.7.5. Thailand Whole Exome Sequencing Market, 2018 – 2030 (USD Million)
9.4.8. South Korea
9.4.8.1. Key Country Dynamics
9.4.8.2. Target Disease Prevalence
9.4.8.3. Competitive Scenario
9.4.8.4. Regulatory Framework
9.4.8.5. South Korea Whole Exome Sequencing Market, 2018 – 2030 (USD Million)
9.5. Latin America
9.5.1. SWOT Analysis
9.5.2. Latin America Whole Exome Sequencing Market, 2018 – 2030 (USD Million)
9.5.3. Brazil
9.5.3.1. Key Country Dynamics
9.5.3.2. Target Disease Prevalence
9.5.3.3. Competitive Scenario
9.5.3.4. Regulatory Framework
9.5.3.5. Brazil Whole Exome Sequencing Market, 2018 – 2030 (USD Million)
9.5.4. Mexico
9.5.4.1. Key Country Dynamics
9.5.4.2. Target Disease Prevalence
9.5.4.3. Competitive Scenario
9.5.4.4. Regulatory Framework
9.5.4.5. Mexico Whole Exome Sequencing Market, 2018 – 2030 (USD Million)
9.5.5. Argentina
9.5.5.1. Key Country Dynamics
9.5.5.2. Target Disease Prevalence
9.5.5.3. Competitive Scenario
9.5.5.4. Regulatory Framework
9.5.5.5. Argentina Whole Exome Sequencing Market, 2018 – 2030 (USD Million)
9.6. MEA
9.6.1. SWOT Analysis
9.6.2. MEA Whole Exome Sequencing Market, 2018 – 2030 (USD Million)
9.6.3. South Africa
9.6.3.1. Key Country Dynamics
9.6.3.2. Target Disease Prevalence
9.6.3.3. Competitive Scenario
9.6.3.4. Regulatory Framework
9.6.3.5. South Africa Whole Exome Sequencing Market, 2018 – 2030 (USD Million)
9.6.4. Saudi Arabia
9.6.4.1. Key Country Dynamics
9.6.4.2. Target Disease Prevalence
9.6.4.3. Competitive Scenario
9.6.4.4. Regulatory Framework
9.6.4.5. Saudi Arabia Whole Exome Sequencing Market, 2018 – 2030 (USD Million)
9.6.5. UAE
9.6.5.1. Key Country Dynamics
9.6.5.2. Target Disease Prevalence
9.6.5.3. Competitive Scenario
9.6.5.4. Regulatory Framework
9.6.5.5. UAE Whole Exome Sequencing Market, 2018 – 2030 (USD Million)
9.6.6. Kuwait
9.6.6.1. Key Country Dynamics
9.6.6.2. Target Disease Prevalence
9.6.6.3. Competitive Scenario
9.6.6.4. Regulatory Framework
9.6.6.5. Kuwait Whole Exome Sequencing Market, 2018 – 2030 (USD Million)
Chapter 10. Competitive Landscape
10.1. Company Categorization
10.2. Strategy Mapping
10.3. Company Market Share Analysis, 2022
10.4. Company Profiles/Listing
10.4.1. Thermo Fisher Scientific, Inc.
10.4.1.1. Overview
10.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.4.1.3. Product Benchmarking
10.4.1.4. Strategic Initiatives
10.4.2. Illumina, Inc.
10.4.2.1. Overview
10.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.4.2.3. Product Benchmarking
10.4.2.4. Strategic Initiatives
10.4.3. Agilent Technologies, Inc
10.4.3.1. Overview
10.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.4.3.3. Product Benchmarking
10.4.3.4. Strategic Initiatives
10.4.4. BGI
10.4.4.1. Overview
10.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.4.4.3. Product Benchmarking
10.4.4.4. Strategic Initiatives
10.4.5. PacBio
10.4.5.1. Overview
10.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.4.5.3. Product Benchmarking
10.4.5.4. Strategic Initiatives
10.4.6. Oxford Nanopore Technologies plc.
10.4.6.1. Overview
10.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.4.6.3. Product Benchmarking
10.4.6.4. Strategic Initiatives
10.4.7. Azenta US Inc. (GENEWIZ)
10.4.7.1. Overview
10.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.4.7.3. Product Benchmarking
10.4.7.4. Strategic Initiatives
10.4.8. CD Genomics
10.4.8.1. Overview
10.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.4.8.3. Product Benchmarking
10.4.8.4. Strategic Initiatives
10.4.9. Novogene Co, Ltd
10.4.9.1. Overview
10.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.4.9.3. Product Benchmarking
10.4.9.4. Strategic Initiatives
10.4.10. Eurofins Genomics
10.4.10.1. Overview
10.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.4.10.3. Product Benchmarking
10.4.10.4. Strategic Initiatives

List of Tables

Table 1 List of abbreviations
Table 2 Global whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 3 Global whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 4 Global whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 5 Global whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 6 Global whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 7 Global whole exome sequencing market, by region, 2018 - 2030 (USD Million)
Table 8 North America whole exome sequencing market, by country, 2018 - 2030 (USD Million)
Table 9 North America whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 10 North America Whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 11 North America Whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 12 North America Whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 13 North America whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 14 U.S. whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 15 U.S. whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 16 U.S. whole Exome Sequencing Market, by workflow, 2018 - 2030 (USD Million)
Table 17 U.S. whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 18 U.S. whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 19 Canada whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 20 Canada whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 21 Canada whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 22 Canada whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 23 Canada whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 24 Europe whole exome sequencing market, by country, 2018 - 2030 (USD Million)
Table 25 Europe whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 26 Europe whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 27 Europe whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 28 Europe whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 29 Europe whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 30 UK whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 31 UK whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 32 UK whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 33 UK whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 34 UK whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 35 Germany whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 36 Germany whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 37 Germany whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 38 Germany whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 39 Germany whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 40 France whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 41 France whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 42 France whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 43 France whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 44 France whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 45 Italy whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 46 Italy whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 47 Italy whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 48 Italy whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 49 Italy whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 50 Spain whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 51 Spain whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 52 Spain whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 53 Spain whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 54 Spain whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 55 Denmark whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 56 Denmark whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 57 Denmark whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 58 Denmark whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 59 Denmark whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 60 Sweden whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 61 Sweden whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 62 Sweden whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 63 Sweden whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 64 Sweden whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 65 Norway whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 66 Norway whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 67 Norway whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 68 Norway whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 69 Norway whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 70 Asia Pacific whole exome sequencing market, by country, 2018 - 2030 (USD Million)
Table 71 Asia Pacific whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 72 Asia Pacific whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 73 Asia Pacific whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 74 Asia Pacific whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 75 Asia Pacific whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 76 Japan whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 77 Japan whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 78 Japan whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 79 Japan whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 80 Japan whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 81 China whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 82 China whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 83 China whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 84 China whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 85 China whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 86 India whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 87 India whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 88 India whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 89 India whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 90 India whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 91 Australia whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 92 Australia whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 93 Australia whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 94 Australia whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 95 Australia whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 96 Thailand whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 97 Thailand whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 98 Thailand whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 99 Thailand whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 100 Thailand whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 101 South Korea whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 102 South Korea whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 103 South Korea whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 104 South Korea whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 105 South Korea whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 106 Latin America whole exome sequencing market, by country, 2018 - 2030 (USD Million)
Table 107 Latin America whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 108 Latin America whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 109 Latin America whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 110 Latin America whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 111 Latin America whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 112 Brazil whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 113 Brazil whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 114 Brazil whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 115 Brazil whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 116 Brazil whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 117 Mexico whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 118 Mexico whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 119 Mexico whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 120 Mexico whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 121 Mexico whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 122 Argentina whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 123 Argentina whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 124 Argentina whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 125 Argentina whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 126 Argentina whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 127 Middle East & Africa whole exome sequencing market, by country, 2018 - 2030 (USD Million)
Table 128 Middle East & Africa whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 129 Middle East & Africa whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 130 Middle East & Africa whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 131 Middle East & Africa whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 132 Middle East & Africa whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 133 South Africa whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 134 South Africa whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 135 South Africa whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 136 South Africa whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 137 South Africa whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 138 Saudi Arabia whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 139 Saudi Arabia whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 140 Saudi Arabia whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 141 Saudi Arabia whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 142 Saudi Arabia whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 143 UAE whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 144 UAE whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 145 UAE whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 146 UAE whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 147 UAE whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 148 Kuwait whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 149 Kuwait whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 150 Kuwait whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 151 Kuwait whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 152 Kuwait whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)

★調査レポート[世界の全エクソームシーケンス市場2023-2030:製品別(機器、消耗品、サービス)、技術別、ワークフロー別、用途別、エンドユーザー別、地域別] (コード:GRV23JUN109)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の全エクソームシーケンス市場2023-2030:製品別(機器、消耗品、サービス)、技術別、ワークフロー別、用途別、エンドユーザー別、地域別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆